Lincomycin Hydrochloride API is the hydrochloride salt of lincomycin, a naturally derived lincosamide antibiotic with activity primarily against susceptible Gram-positive bacteria and certain anaerobic microorganisms. Lincomycin was originally identified from Streptomyces lincolnensis and has been developed into pharmaceutical preparations for antibacterial applications.
Lincomycin Hydrochloride belongs to the lincosamide class of antibacterial agents and exerts its activity primarily by inhibiting bacterial protein synthesis. It binds to the bacterial 50S ribosomal subunit and interferes with peptide-chain formation, thereby inhibiting bacterial growth.
The anhydrous hydrochloride form is identified by CAS No. 859-18-7, with molecular formula C₁₈H₃₅ClN₂O₆S and molecular weight approximately 443.0 g/mol.
Lincomycin Hydrochloride is relevant to pharmaceutical development involving antibacterial formulations, lincosamide antibiotics, Gram-positive bacterial research, anaerobic bacterial research, pharmaceutical formulation development and analytical quality-control applications.
MEDIOCON INC supplies Lincomycin Hydrochloride for applicable pharmaceutical manufacturing, formulation development, analytical research and bulk API requirements, subject to product availability, applicable regulatory requirements and supporting documentation. The exact salt/hydrate form, assay basis, impurity profile, water content, potency, packaging and Certificate of Analysis should be confirmed for the specific batch.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Lincomycin Hydrochloride API Manufacturer & Supplier in India | MEDIOCON INC (CAS 859-18-7) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Lincomycin Hydrochloride API Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance